Hc Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Hc Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$75.71 - $119.24 $154,599 - $243,488	2,042 New	2,042 $226,000
Q1 2021 May 07, 2021	SELL	$72.25 - $168.95 $309,374 - $723,443	-4,282 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$125.56 - $178.74 $64,663 - $92,051	515 Added 13.67%	4,282 $730,000
Q3 2020 Nov 04, 2020	BUY	$127.12 - $172.34 $41,441 - $56,182	326 Added 9.47%	3,767 $529,000
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $320,013 - $590,819	3,441 New	3,441 $552,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.